Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer — Ludovic Barault (2015) | RDL Network
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
Carmen Balañá, Cristina Carrato, José Luis Ramírez, Andrés F. Cardona, Mireia Berdiel‐Acer, José Javier Sánchez, Miquel Tarón, C. Hostalot, Eva Musulen, Aurelio Ariza, Rafael Rosell
Discussion(0)
No comments yet. Be the first to comment.